108 related articles for article (PubMed ID: 29783295)
41. Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
Pasipoularides A
Int J Cardiol; 2017 Mar; 230():384-401. PubMed ID: 28057368
[TBL] [Abstract][Full Text] [Related]
42. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
Squassina A; Manchia M; Manolopoulos VG; Artac M; Lappa-Manakou C; Karkabouna S; Mitropoulos K; Del Zompo M; Patrinos GP
Pharmacogenomics; 2010 Aug; 11(8):1149-67. PubMed ID: 20712531
[TBL] [Abstract][Full Text] [Related]
43. Towards a framework for personalized healthcare: lessons learned from the field of rare diseases.
Tambuyzer E
Per Med; 2010 Sep; 7(5):569-586. PubMed ID: 29776250
[TBL] [Abstract][Full Text] [Related]
44. Clinical decision support for personalized medicine: an opportunity for pharmacist-physician collaboration.
Barlow JF
Per Med; 2012 Jun; 9(4):441-450. PubMed ID: 29776258
[TBL] [Abstract][Full Text] [Related]
45. Personalized medicine: the absence of 'model-changing' financial incentives.
Keeling P
Per Med; 2007 Feb; 4(1):73-81. PubMed ID: 29793300
[TBL] [Abstract][Full Text] [Related]
46. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
[TBL] [Abstract][Full Text] [Related]
47. The business value and cost-effectiveness of genomic medicine.
Crawford JM; Aspinall MG
Per Med; 2012 May; 9(3):265-286. PubMed ID: 29758798
[TBL] [Abstract][Full Text] [Related]
48. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
49. Clinical practice on the horizon: personalized medicine.
Chadwell K
Clin Nurse Spec; 2013; 27(1):36-43. PubMed ID: 23222027
[TBL] [Abstract][Full Text] [Related]
50. [Reduction of Treatment Duration in Periprosthetic Infection with a Fast-Track Concept Is Economically Not Feasible].
Lieb E; Hanstein T; Schuerings M; Trampuz A; Perka C
Z Orthop Unfall; 2015 Dec; 153(6):618-23. PubMed ID: 26468925
[TBL] [Abstract][Full Text] [Related]
51. Personalized medicine: are payers the weak link?
Cohen JP
Per Med; 2011 May; 8(3):293-296. PubMed ID: 29783526
[No Abstract] [Full Text] [Related]
52. The re-emerging concept of personalized healthcare.
Xu LH; Zheng H; Sedmak DD; Sadée W
Per Med; 2008 Sep; 5(5):457-469. PubMed ID: 29783441
[TBL] [Abstract][Full Text] [Related]
53. Understanding the economic value of molecular diagnostic tests: case studies and lessons learned.
Towse A; Ossa D; Veenstra D; Carlson J; Garrison L
J Pers Med; 2013 Oct; 3(4):288-305. PubMed ID: 25562729
[TBL] [Abstract][Full Text] [Related]
54. Personalized medicine 2014: has healthcare been transformed?
Snyderman R
Per Med; 2014 Jun; 11(4):365-368. PubMed ID: 29783483
[No Abstract] [Full Text] [Related]
55. Initial development of an evidence base for personalized medicine's translation to clinical practice and health policy.
Phillips KA; Van Bebber SL; Issa AM
Per Med; 2006 Nov; 3(4):411-414. PubMed ID: 29788589
[TBL] [Abstract][Full Text] [Related]
56. Translating pharmacogenomics discoveries into the clinic: an implementation framework.
Huang RS; Gamazon ER
Genome Med; 2013; 5(10):94. PubMed ID: 24134796
[TBL] [Abstract][Full Text] [Related]
57. Advocacy in personalized medicine: a developing strength in a complex space.
Miller I; Pothier K; Dunn M
Per Med; 2010 Mar; 7(2):179-186. PubMed ID: 29783322
[TBL] [Abstract][Full Text] [Related]
58. After the revolution? Ethical and social challenges in 'personalized genomic medicine'.
Juengst ET; Settersten RA; Fishman JR; McGowan ML
Per Med; 2012 Jun; 9(4):429-439. PubMed ID: 23662108
[TBL] [Abstract][Full Text] [Related]
59. The impact of healthcare reform on payers' products, provider reimbursement, and member engagement.
Muppalla S; Capobianco R
Am Health Drug Benefits; 2010 Jul; 3(4):289-90. PubMed ID: 25126322
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
